Terms: = Liver cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Clinical Outcome
3 results:
1. A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma.
Singh V; Manalang M; Singh M; Apte U
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):654-657. PubMed ID: 28187036
[TBL] [Abstract] [Full Text] [Related]
2. Bilateral adrenal neuroblastoma.
Zaizen Y; Suita S; Yamanaka K; Nagoshi M; Tsuda T
Eur J Pediatr Surg; 1997 Oct; 7(5):304-7. PubMed ID: 9402493
[TBL] [Abstract] [Full Text] [Related]
3. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, n-myc oncogene amplification, and patient outcome.
Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
[TBL] [Abstract] [Full Text] [Related]
